C2orf43 Antibody (YA8230)
(Synonyms: C2orf43; hLDAH)C2orf43 Antibody (YA8230) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to C2orf43.
-
Host:
Mouse
-
Isotype:
IgG1
-
Application:
FC
-
Reactivity :
Human
-
Formulation:
Spplied in PBS (pH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide.
-
Conjugation:
Non-conjugated
Applications
| Application |
FC
FC: Flow Cytometry
|
|---|---|
| Dilution Ratio | 1:100 |
Product Details
C2orf43 Antibody (YA8230) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to C2orf43.
-
Host Mouse
-
Clonality Monoclonal
-
Species ReactivityHuman
-
Calculated Molecular Weight Predicted band size: 37.1 kDa
Full length human recombinant protein of human C2orf43 produced in HEK293T cell.
Endogenous
Affinity purified
Non-conjugated
Unmodified
IgG1
Product Properties
-
Appearance
Liquid
-
Formulation
Spplied in PBS (pH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide.
-
Storage & Stability
Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.
-
Shipping
Shipping with blue ice.
Background
-
Function
C2orf43 is a Probable serine lipid hydrolase associated with lipid droplets. Has low cholesterol esterase activity. Appears to lack triglyceride lipase activity. Involved in cholesterol and triglyceride homeostasis; has opposing effects, stimulating cellular triglyceride accumulation and cellular cholesterol release. Acts antagonistically with PNPLA2/ATGL in regulation of cellular lipid stores. May regulate triglyceride accumulation indirectly through stimulation of PNPLA2/ATGL ubiquitination and proteasomal degradation. Promotes microtubule-dependent lipid droplet fusion. Highly expressed in macrophage-rich areas in atherosclerotic lesions, suggesting that it could promote cholesterol ester turnover in macrophages[1][2].
-
Subcellular Localization
Lipid droplet,Endoplasmic reticulum
-
Expression
Tissue_Specificity: Present in macrophage-rich areas in atherosclerotic lesions (at protein level) (PubMed:24357060). Expressed in monocytes and monocyte-derived macrophages (at protein level) (PubMed:24357060) -
Isoforms & Post-Translational Modification
Q9H6V9 has four isomers: Q9H6V9-1: 37319 Da (predicted); Q9H6V9-2: 37989 Da (predicted); Q9H6V9-3: 32029 Da (predicted); Q9H6V9-4: 22663 Da (predicted).
-
SwissProt ID
-
Synonyms
C2orf43; hLDAH
Documentation